Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain

OBJECTIVE: To explore adherence/persistence with generic gabapentin/venlafaxine versus brand-name gabapentin/venlafaxine (Neurontin(®)/Vandral(®)) in peripheral neuropathic pain (pNP) or generalized anxiety disorder (GAD), respectively, and whether it is translated into different costs and patient o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clinicoecon Outcomes Res
Autores principales: Sicras-Mainar, Antoni, Rejas-Gutiérrez, Javier, Navarro-Artieda, Ruth
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461091/
https://ncbi.nlm.nih.gov/pubmed/26082655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S85756
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares